Quality indicators in the ovarian cancer program
| Quality indicators | Goal |
| Patient care | |
| Proportion of patients with complete surgical resection in upfront debulking or interval debulking surgery | >65% |
| Proportion of patients receiving antibiotic prophylaxis 60 min before starting cytoreductive surgery | 100% |
| Proportion of patients receiving pharmacological anti-thrombotic prophylaxis within 24 hours of cytoreduction | 100% |
| Proportion of patients who presented operative site infection during the 30 days after the procedure | <5% |
| Proportion of patients who start adjuvant chemotherapy within 42 days after debulking surgery | 100% |
| Proportion of patients who completed the EORTC-QLQC30 quality of life questionnaire before starting cancer treatment | 100% |
| Proportion of patients who completed the EORTC-QLQC30 quality of life questionnaire after completing cancer treatment | 100% |
| Infrastructure | |
| Number of cytoreductive surgeries performed per surgeon per year | >100 Minimum required: >20 |
| Surgeries supervised or performed by surgeons operating on at least 20 patients a year | ≥95% |
| Rate of primary debulking surgeries | ≥50% |
| Surgery performed by a gynecologic oncologist specifically dedicated to gynecological cancer management | Yes |
| Center participating in clinical trials in gynecologic oncology | Yes |
| Treatment planned and reviewed at a multidisciplinary team meeting | ≥90% |
| Required pre-operative workup | ≥95% |
| Pre-operative, intra-operative, and post-operative management | Yes |
| Minimum required elements in operative reports | 90% |
| Minimum required elements in pathology reports | >90% |
| Structured prospective reporting of post-operative complications | 100% |
Adapted from Fotopolou et al.9 Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update. Int J Gynecol Cancer 2020;30:436–40.